ISSN: 2041-5990

Journal Home

Journal Guideline

Therapeutic delivery Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Therapeutic delivery is a journal indexed in SJR in Pharmaceutical Science with an H index of 63. It has an SJR impact factor of 0,455 and it has a best quartile of Q2. It has an SJR impact factor of 0,455.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,455

SJR Impact factor

63

H Index

56

Total Docs (Last Year)

177

Total Docs (3 years)

3281

Total Refs

480

Total Cites (3 years)

157

Citable Docs (3 years)

2.16

Cites/Doc (2 years)

58.59

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmaceutical Research Q2
Journal of Pharmaceutical Sciences Q2
Drug Metabolism and Pharmacokinetics Q2
Journal of Texture Studies Q2
Cancer Nanotechnology Q2

Compare this journals

Aims and Scope

Best articles by citations

Optically modulated cancer therapeutic delivery: past, present and future

Glycan-targeted drug delivery for intravesical therapy: in the footsteps of uropathogenic bacteria

Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient

PLGA carriers for inhalation: where do we stand, where are we headed?

The advantages of pulmonary delivery of therapeutic siRNA

Opportunities in respiratory drug delivery

Intracellular delivery of RNA-based therapeutics using aptamers

Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma

The therapeutic potential of vaginal drug delivery in the treatment of cervical cancer

Zanamivir oral delivery: possibilities revisited

Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules

pH-sensitive liposomes for drug delivery in cancer treatment

SHOW MORE ARTICLES

Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects

A pharmaceutics perspective on drug delivery to the nail: recent advances and challenges

Vesicle-based artificial cells: recent developments and prospects for drug delivery

Receptor-targeted drug delivery: current perspective and challenges

Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson's disease

Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells

Delivering the promise of small ncRNA therapeutics

Importance of controlled delivery systems for regenerative therapeutics

Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy

Challenges and new strategies for therapeutic peptide delivery to the CNS

Cells as delivery vehicles for cancer therapeutics

Recent developments in silicones for topical and transdermal drug delivery